These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 6976414)
1. In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration. Ozer H; Cowens JW; Colvin M; Nussbaum-Blumenson A; Sheedy D J Exp Med; 1982 Jan; 155(1):276-90. PubMed ID: 6976414 [TBL] [Abstract][Full Text] [Related]
2. In vitro effects of 4-hydroxyperoxycyclophosphamide on human immunoregulatory T subset function. Smith JJ; Mihich E; Ozer H Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):555-68. PubMed ID: 2893863 [TBL] [Abstract][Full Text] [Related]
3. Functional analysis of human T cell subsets defined by monoclonal antibodies. VI. Distinct and opposing immunoregulatory functions within the OKT8+ population. Thomas Y; Rogozinski L; Rabbani L; Chess A; Goldstein G; Chess L J Mol Cell Immunol; 1984; 1(2):103-13. PubMed ID: 6152892 [TBL] [Abstract][Full Text] [Related]
4. T-suppressor cells sensitive to cyclophosphamide and to its in vitro active derivative 4-hydroperoxycyclophosphamide control the mitogenic response of murine splenic B cells to dextran sulfate. A direct proof for different sensitivities of lymphocyte subsets to cyclophosphamide. Diamantstein T; Willinger E; Reiman J J Exp Med; 1979 Dec; 150(6):1571-6. PubMed ID: 159940 [TBL] [Abstract][Full Text] [Related]
5. Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique. Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T J Clin Invest; 1983 Dec; 72(6):2060-71. PubMed ID: 6227636 [TBL] [Abstract][Full Text] [Related]
6. Differences in sensitivity to melphalan between con A-activated and nonactivated human T-cell subsets. Komlos L; Ben-Efraim S; Notmann J; Hart J; Halbrecht I Clin Immunol Immunopathol; 1987 Oct; 45(1):105-13. PubMed ID: 3497748 [TBL] [Abstract][Full Text] [Related]
7. Effect of ASTA Z 7557 (INN mafosfamide) a precursor of 4-hydroxy-cyclophosphamide on human T-lymphocytes' Fc-receptors and immunoregulatory functions. Saal JG; Hadam M; Frank F; Rautenstrauch H; Fritz P Invest New Drugs; 1984; 2(2):231-5. PubMed ID: 6236165 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the relationship between T cell subsets and in vitro B cell responses in multiple myeloma. Levinson AI; Hoxie JA; Matthews DM; Schreiber AD; Negendank WG J Clin Lab Immunol; 1985 Jan; 16(1):23-6. PubMed ID: 3872370 [TBL] [Abstract][Full Text] [Related]
9. Dose-response effects of 4-hydroperoxycyclophosphamide on human T and B cell function in vitro. Kodo H; Bonavida B; Colvin M; Gale RP Int J Immunopharmacol; 1985; 7(4):555-60. PubMed ID: 2931385 [TBL] [Abstract][Full Text] [Related]
10. Functional analysis of human T cell subsets defined by monoclonal antibodies. I. Collaborative T-T interactions in the immunoregulation of B cell differentiation. Thomas Y; Sosman J; Irigoyen O; Friedman SM; Kung PC; Goldstein G; Chess L J Immunol; 1980 Dec; 125(6):2402-8. PubMed ID: 6968783 [TBL] [Abstract][Full Text] [Related]
11. B cell activation by pokeweed mitogen in cultures of normal peripheral blood lymphocytes depleted of T regulator subsets by treatment with OKT4 and OKT8 monoclonal antibodies. Jones BM Clin Exp Immunol; 1983 Mar; 51(3):461-9. PubMed ID: 6221842 [TBL] [Abstract][Full Text] [Related]
12. In vitro induction of a contrasuppressor immunoregulatory network by polyclonally activated T cells derived from murine Peyer's patches. Kawanishi H; Kiely J Immunology; 1988 Mar; 63(3):415-21. PubMed ID: 2965098 [TBL] [Abstract][Full Text] [Related]
13. Immunoregulatory activity of T-cell subsets activated in human mixed lymphocyte reaction. Goeken NE; Melton ZJ Hum Immunol; 1983 Feb; 6(2):79-90. PubMed ID: 6219973 [TBL] [Abstract][Full Text] [Related]
14. Further dissection of the functional heterogeneity within the OKT4+ and OKT8+ human T cell subsets. Thomas Y; Rogozinski L; Rothman P; Rabbani LE; Andrews S; Irigoyen OH; Chess L J Clin Immunol; 1982 Jul; 2(3 Suppl):8S-14S. PubMed ID: 6215426 [TBL] [Abstract][Full Text] [Related]
15. Immunoregulatory T cell function in multiple myeloma. Ozer H; Han T; Henderson ES; Nussbaum A; Sheedy D J Clin Invest; 1981 Mar; 67(3):779-89. PubMed ID: 6451635 [TBL] [Abstract][Full Text] [Related]
16. Depressed effector activity of OKT4+ and OKT8+ T cell subsets in lectin-dependent cell-mediated cytotoxicity to HEP-2 cells in patients with systemic lupus erythematosus. Perl A; Gonzalez-Cabello R; Gergely P J Clin Lab Immunol; 1984 Oct; 15(2):95-100. PubMed ID: 6240539 [TBL] [Abstract][Full Text] [Related]
17. Modulation of suppressor cell activities by cyclophosphamide in breast cancer patients. Kuroi K; Sato Y; Yamaguchi Y; Toge T J Clin Lab Anal; 1994; 8(3):123-7. PubMed ID: 8046538 [TBL] [Abstract][Full Text] [Related]
18. Suppression of human B lymphocyte function by cyclophosphamide. Cupps TR; Edgar LC; Fauci AS J Immunol; 1982 Jun; 128(6):2453-7. PubMed ID: 6978904 [TBL] [Abstract][Full Text] [Related]
19. B lymphocyte function in patients with rheumatoid arthritis: impact of regulatory T lymphocytes and macrophages--modulation by antirheumatic drugs. Petersen J Dan Med Bull; 1988 Apr; 35(2):140-57. PubMed ID: 3282810 [TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of concanavalin A-induced suppressor T cells in man defined with monoclonal antibodies. Damle NK; Gupta S Clin Exp Immunol; 1982 Jun; 48(3):581-8. PubMed ID: 6214339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]